Exciting News from BioPharma Services Inc. 📣 We are thrilled to announce that today, BioPharma Services has been acquired by HEALWELL AI, a leader in innovative AI applications in healthcare technology. HEALWELL AI, with WELL Health Technologies Corp. (TSX: WELL) as its largest shareholder, is renowned for its advanced technologies in early disease diagnosis and personalized treatment. This acquisition allows us to leverage HEALWELL's data science expertise to further improve our service offerings. This acquisition marks a significant milestone in our journey to expand our capabilities and enhance our service offerings within the clinical research industry including research in rare diseases. We want to take a moment to thank Think Research for their invaluable partnership and support over the years. Read the full announcement here: https://hubs.li/Q02BLFML0 For more information about HEALWELL AI, visit their website: https://hubs.li/Q02BLG9Y0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioequivalence, bioavailability, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #biopharma #clinicalresearch #clinicalstudies #clinicaltrials
BioPharma Services Inc.
Pharmaceutical Manufacturing
Toronto, ON 17,082 followers
Full-Service CRO delivering excellence in early stage clinical research, from Phase I & HAL trials to BE/BA studies.
About us
BioPharma Services Inc. is a full-service Contract Research Organization (CRO) specializing in Phase I/IIa, Bioequivalence, Human Abuse Liability, PET Imaging and Psychedelic Studies. With over 17 years of industry experience, and a primary research facility in Toronto, Canada, our team of experts are dedicated to delivering superior quality service and reliable research results. BioPharma Services offers in-house, GLP/GCP preclinical and clinical bioanalytical services, featuring LC-MS/MS technology at our Toronto facility. We prioritize ethical subject recruitment and comply with all major international regulatory bodies, including the FDA, Health Canada, and ANVISA. We have been successfully inspected by all major regulatory bodies, and are dedicated to building and maintaining long-lasting relationships with our Global clients through superior quality service, timely and reliable research results. Highlights of our experience: → State-of-the-art Clinical facility in Canada with over 150 bed capacity → 99% enrolment for all Phase I studies with a 95% completion rate → Timely study start up: 30 Day CTA, Weekly IRB/Ethics review → 20,000 active subject database of patients, special populations & healthy volunteers → Full service capabilities: Regulatory, Scientific and Medical Affairs, Comprehensive Project Management, Data Management, Biostatistical Analysis with CDISC data standards (SDTM and ADaM datasets), Medical Writing and more.
- Website
-
https://www.biopharmaservices.com
External link for BioPharma Services Inc.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Toronto, ON
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Bioequivalence (BE) Studies, Phase I/IIa clinical trials, Pharmacokinetic Analysis, Regulatory Affairs, Data Management, Quality Assurance, Project Management, Statistical Services, Human Abuse Liability/Potential, Biometrics/CDISC, Bioavailability, Psychedelic Research, Clinical trial monitoring, Medical and regulatory writing, pharmacovigilance, Subject recruitment and retention services, Rare disease studies, PET Studies, and Full-service CRO
Locations
-
Primary
4000 Weston Road
Toronto, ON M9L 3A2, CA
Employees at BioPharma Services Inc.
-
Jennifer Branch
Operations Management/Administration Professional
-
Juan He
Vice President, Pharmacometrics at Biopharma Services Inc
-
Tania Pannunzio
Senior Director, Data Management and Biostatistics at BioPharma Services Inc.
-
John Oldenhof
Executive Vice President, Scientific Affairs at BioPharma Services Inc.
Updates
-
🔎 Got your NOL? Here’s what comes next. Listen in as Negar Gharavi walks us through the post-approval processes every sponsor needs to know after receiving their Notice of Authorization (NOL). From submitting your Clinical Trial Site Information (CTSI) to ongoing amendments and reporting—learn how to keep your clinical trial compliant with Health Canada regulations. Watch the full clip and stay ahead of your regulatory obligations below. 🔗https://hubs.li/Q02RffWh0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioequivalence, bioavailability, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #biopharma #clinicalresearch #clinicalstudies #clinicaltrials #bioanalytics #webinar
-
#WhatIf ― We Could Stop Aging? 💡Let's Discuss! Imagine a world where aging is no longer inevitable or could be under our control. We think the possibilities are endless: more time to pursue passions, deepen relationships, and explore the universe of knowledge. With eternal youth comes some profound questions: 🔹 How would society adapt to limitless lifespans? 🔹 What about resources and the environment? 🔹 How would our perspectives on life and legacy change? Let’s dream big and think critically! How do YOU envision a world where aging is cured? Share your thoughts below! 👇 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry
-
Will you be in Northern Italy for CPhI Milan in 1 week? We are excited to announce that our Phase 1 & BE expert Mo H. , will be attending the upcoming CPhI Conferences. Meet with Mo to discuss our capabilities in supporting your next drug development project. BioPharma Services Inc. specializes in #Phase1 clinical trials, bioequivalence, bioavailability, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. #biopharma #clinicalresearch #clinicalstudies #clinicaltrials #bioanalytics #cphi #cphimilan #bioequivalence #generics
-
🔬 Is RNA-Targeted Therapy the Future of Genetic Disease Treatment? Let's talk. With RNA-targeted therapies like ASOs, siRNA, and gene editing techniques such as CRISPR-Cas9, we’re seeing remarkable progress in conditions like Spinal Muscular Atrophy and Duchenne Muscular Dystrophy. But despite this promise, challenges like delivery, off-target effects, and safety remain key concerns. 💬 How do you see these therapies evolving in the next 5-10 years? Will improved delivery methods or precision gene editing be the game changer we need? Join the discussion! We want to hear your thoughts on how we can overcome the current challenges and bring these cutting-edge therapies to more patients. Learn more here 👇 https://hubs.li/Q02Rf2CB0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry
RNA-Targeted Therapies & Phase 1 Trials - BioPharma Services
https://www.biopharmaservices.com
-
BioPharma Services Inc. reposted this
I prefer conference hopping over bar hopping!! #OECT Day 2 at OECT Operational Excellence in Clinical Trials 8th Annual Summit. Had the chance to reconnect with some old friends and investigators! Representing BioPharma Services Inc. alongside team Khure Health Sonny Kohli, MD FRCPC spoke about Khure Health’s AI driven Patient identification platform along with the massive potential it has to change the way we view Patient recruitment. Throw in the word “Free to use” and the crowd went wild! Don Watts further spoke about the accessibility of this platform and its potential across not just Canada but across North America.
-
🔔 Last Call! 🔔 The BioBridges Conference 2024 wraps up today, but there's still a golden opportunity awaiting you! Our Director of Business Development, Mo H. and Director of Pharmacokinetics, Sunny Le are present and eager to connect with you. If you're at the conference or in the vicinity, don't miss this chance to discuss potential clinical collaborations and industry insights! BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world renowned Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #cro #clinicaltrials #Biopharma #drugdevelopment #phase1 #biobridges #biobridges2024 #prauge
-
Did you know that only 5% of rare diseases have an approved treatment. At BioPharma Services, we understand that behind every rare disease diagnosis is a patient, a family, and a community searching for hope. Through our partnerships with industry innovators, we’re helping to turn that hope into reality by supporting clinical trials that bring ground breaking therapies to those who need them most. "As someone personally connected to rare disease advocacy, I know how critical it is to turn scientific breakthroughs into real treatments for patients. At BioPharma, we’re proud to help biotech companies bring those life-changing therapies to families like mine." – Dr. John Oldenof, VP of Scientific Affairs. As we celebrate Global BioTech Week 2024, we’re proud to stand at the intersection of biotechnology and rare disease research, working towards a future where no patient or family is left behind. Read more here 👇 https://hubs.li/Q02Rdf3n0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry #GBW2024 #GlobalBiotechWeek #RareDiseaseResearch
Genetic Epilepsies - A New Frontier For Drug Development
-
BioPharma Services Achieves Another Milestone in Quality Excellence 🏆 We’re excited to announce the successful completion of an FDA Good Clinical Practice (GCP) inspection at our Toronto facility. The weeklong audit concluded with no Form 483 issued. This thorough inspection reinforces our commitment to safeguarding study participants, maintaining data reliability, and upholding the highest standards of integrity in our clinical trial processes. BioPharma Services remains dedicated to conducting research that meets the stringent requirements of health organizations worldwide. Read more here 👇 https://hubs.li/Q02QXTW10 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry
FDA Concludes Successful Inspection of BioPharma Services
https://www.biopharmaservices.com
-
RNA therapies are opening doors for new treatments, but challenges remain. Effective delivery to tissues like the brain or muscle, minimizing side effects, and making these treatments scalable are just a few hurdles. At BioPharma Services, we are working hard to tackle these obstacles in our work. 💬 Vote and share your perspective—what’s the toughest challenge to overcome? Learn more here 👇 https://hubs.li/Q02PH8lr0 BioPharma Services Inc. specializes in #Phase1 clinical trials, bioavailability, bioequivalence, First-in-Human and Human Abuse Potential Studies (#HAP). Let our world-renowned #Pharmacokinetics team execute your next clinical trial with confidence. . . . #clinicalresearch #clinicalstudies #clinicaltrials #bioanalsysis #cro #clinicaltrials #Biopharma #drugdevelopment #biotech #pharmaceuticalindustry
This content isn’t available here
Access this content and more in the LinkedIn app